Cargando…

Molecular Mechanisms in Lysosomal Storage Diseases: From Pathogenesis to Therapeutic Strategies

Detalles Bibliográficos
Autores principales:	De Pasquale, Valeria, Scarcella, Melania, Pavone, Luigi Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031509/ https://www.ncbi.nlm.nih.gov/pubmed/35453672 http://dx.doi.org/10.3390/biomedicines10040922

Ejemplares similares

Lysosomal positioning diseases: beyond substrate storage
por: Scerra, Gianluca, et al.
Publicado: (2022)

The Key Role of Lysosomal Protease Cathepsins in Viral Infections
por: Scarcella, Melania, et al.
Publicado: (2022)

Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
por: Moro, Enrico
Publicado: (2021)

The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease
por: Cocchiaro, Pasquale, et al.
Publicado: (2017)

Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases
por: Belfiore, Maria Paola, et al.
Publicado: (2020)

Therapeutic Approaches in Lysosomal Storage Diseases
por: Fernández-Pereira, Carlos, et al.
Publicado: (2021)

Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses
por: De Pasquale, Valeria, et al.
Publicado: (2018)

Editorial: Mitochondrial and lysosomal dysfunction in neurodegenerative diseases: Molecular mechanisms and therapeutic strategies
por: Xiang, Chen, et al.
Publicado: (2022)

Lysosomes and Lysosomal Storage Diseases
por: Noebels, Jeffrey L.
Publicado: (1981)

Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies
por: Bernardo, Antonietta, et al.
Publicado: (2023)

A Journey towards Understanding the Molecular Pathology and Developing Therapies for Lysosomal Storage Disorders
por: Tikkanen, Ritva
Publicado: (2021)

Ferroptosis and Its Modulation by Autophagy in Light of the Pathogenesis of Lysosomal Storage Diseases
por: Pierzynowska, Karolina, et al.
Publicado: (2021)

Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases
por: Faverio, Paola, et al.
Publicado: (2019)

EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB
por: De Pasquale, Valeria, et al.
Publicado: (2018)

Lysosomal storage diseases
por: Ferreira, Carlos R., et al.
Publicado: (2017)

Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases
por: Oh, Doo-Byoung
Publicado: (2015)

New paradigms for the treatment of lysosomal storage diseases: targeting the endocannabinoid system as a therapeutic strategy
por: Schuchman, Edward H., et al.
Publicado: (2021)

Rheumatoid Arthritis from Pathogenesis to Therapeutic Strategies
por: Mueller, Ruediger B., et al.
Publicado: (2020)

The Pathogenesis of COVID-19 Indicates Therapeutic Strategies
por: Li, Tai-Sheng, et al.
Publicado: (2021)

Early onset effects of single substrate accumulation recapitulate major features of LSD in patient-derived lysosomes
por: Scerra, Gianluca, et al.
Publicado: (2021)

Therapeutic Strategies against Inflammation-Related Diseases: Molecular Mechanisms and Clinical Applications
por: Wu, Wen-Bin, et al.
Publicado: (2015)

Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
por: Timchenko, Lubov
Publicado: (2022)

Splicing Modulation as a Promising Therapeutic Strategy for Lysosomal Storage Disorders: The Mucopolysaccharidoses Example
por: Santos, Juliana Inês, et al.
Publicado: (2022)

Biomarkers in Lysosomal Storage Diseases
por: Bobillo Lobato, Joaquin, et al.
Publicado: (2016)

Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers
por: Ruiz de Porras, Vicenç, et al.
Publicado: (2023)

Molecular Mechanism and Pathogenesis of Sarcopenia: An Overview
por: Picca, Anna, et al.
Publicado: (2021)

Molecular study of lysosomal storage disorders in India
por: Sheth, Jayesh
Publicado: (2014)

Molecular basis of lysosomal storage disorders in India
por: Kondurkar, Shweta P, et al.
Publicado: (2014)

Pathogenesis and Molecular Mechanisms of Anderson–Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Dysregulation of autophagy as a common mechanism in lysosomal storage diseases
por: Seranova, Elena, et al.
Publicado: (2017)

N-Substituted l-Iminosugars for the Treatment of Sanfilippo Type B Syndrome
por: De Pasquale, Valeria, et al.
Publicado: (2023)

Cellular and Molecular Mechanisms in the Pathogenesis of Multiple Sclerosis
por: Wan, Edwin C. K.
Publicado: (2020)

Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
por: Wang, Jing-Hua
Publicado: (2023)

Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies
por: Mandraffino, Giuseppe, et al.
Publicado: (2022)

Lysosomal Storage Diseases—Regulating Neurodegeneration
por: Onyenwoke, Rob U., et al.
Publicado: (2016)

Neuroinflammatory paradigms in lysosomal storage diseases
por: Bosch, Megan E., et al.
Publicado: (2015)

Modeling Lysosomal Storage Diseases in the Zebrafish
por: Zhang, T., et al.
Publicado: (2020)

Molecular Research on Emerging Viruses: Evolution, Diagnostics, Pathogenesis, and Therapeutics
por: Lau, Susanna K. P.
Publicado: (2018)

Editorial: Neuronopathic lysosomal storage diseases - specific neuronal characteristics and therapeutic approaches
por: Flunkert, Stefanie, et al.
Publicado: (2022)

Lysosomal storage disorders: Molecular basis and laboratory testing
por: Filocamo, Mirella, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nonun5hmvs0n79avvg1kr4dktg